Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. stocks rally on coronavirus drug hopes

Published 04/29/2020, 06:51 AM
Updated 04/29/2020, 04:05 PM
© Reuters. The floor of the New York Stock Exchange (NYSE) stands empty as the building prepares to close indefinitely due to the coronavirus disease (COVID-19) outbreak in New York

By Stephen Culp (NYSE:CULP)

NEW YORK (Reuters) - Wall Street stock indexes surged on Wednesday as hopes for an effective COVID-19 treatment prompted a broad rally and helped investors look past bleak economic data.

Big tech companies returned to the lead, providing the biggest boost to all three major U.S. stock averages and pushing them closer to their all-time highs reached in February.

All are well within 20% of their record levels, with the tech-heavy Nasdaq (NASDAQ:NDAQ) now within 10% of its high.

Smaller companies, which stand to benefit more from restrictions being lifted on a state-by-state basis, continue to outperform their larger counterparts, with the Russell 2000 (RUT) on track for its sixth straight advance.

Drugmaker Gilead Sciences Inc (O:GILD) announced that its drug remdesivir is showing promise as an effective COVID-19 treatment, giving a boost to the broader market and sending its shares up 6.2%.

"There's an anticipation of a potential return to normalcy, with states talking about procedures to slowly reopen cities and towns and get people spending again," said Matthew Keator, managing partner in the Keator Group, a wealth management firm in Lenox, Massachusetts.

"The market is a forward-looking vehicle and it's starting to look up."

U.S. Federal Reserve wrapped up its two-day monetary policy meeting, leaving key interest rates near zero and vowing to use a "full range" of its tools to aid the economy in the face of a pandemic that poses "considerable" medium term risks.

Stocks slightly trimmed their gains after the Fed's statement.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Words matter with the Fed, maybe now more than ever," Keator added. "Because of the uncertainty out there, the Fed is one place markets can find certainty as to what they plan on doing and for how long."

The U.S. economy suffered its sharpest decline in 11 years, with first-quarter GDP contracting at a 4.8% quarterly annualized rate according to the Commerce Department, marking the end of the longest U.S. economic expansion on record.

The Dow Jones Industrial Average (DJI) rose 503.57 points, or 2.09%, to 24,605.12, the S&P 500 (SPX) gained 72.69 points, or 2.54%, to 2,936.08 and the Nasdaq Composite (IXIC) added 286.46 points, or 3.33%, to 8,894.19.

Of the 11 major sectors in the S&P 500, nine were in the black, with energy companies (SPNY) enjoying the largest percentage gain.

Earnings season has hit full-stride, with 192 of the companies in the S&P 500 having reported. Of those, 64.6% have beaten consensus estimates, according to Refinitiv data.

In aggregate, first-quarter S&P 500 earnings are seen dropping 15.1 percent from a year ago, a stark reversal from the 6.3% annual growth forecast on Jan. 1, per Refinitiv.

Google parent Alphabet Inc (O:GOOGL) jumped 9.0% after the company reported steady advertising sales and a 13% year-on-year revenue increase.

Boeing Co (N:BA) shares surged 7.8% after the planemaker announced it would shrink its workforce and production to contend with plunging demand.

Ride share company Lyft Inc (O:LYFT) plans to cut 17% of its workforce, according to a Reuters exclusive. Its shares were up 4.2%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Results from Facebook Inc (O:FB), Microsoft Corp (O:MSFT) and Tesla Inc (O:TSLA) are expected after the closing bell.

Advancing issues outnumbered declining ones on the NYSE by a 6.89-to-1 ratio; on Nasdaq, a 4.81-to-1 ratio favored advancers.

The S&P 500 posted 5 new 52-week highs and no new lows; the Nasdaq Composite recorded 38 new highs and no new lows.

Latest comments

Hope, war threaten, Kim jong un death, and what is more? I have questions.
I am holding my cash. But i know one thing for sure, when i will start buying stocks market will collapse
Hopes every day.... Great
rates unchanged cant lower it even worst for usd
Market didnt respond to huge negative GDP and rallying for hope of bla bla , i think its trick befire the FED speach and rhey wil tke the market all the way down for months to come , we are in supply zone
Another Gilead report on trials was released even though it is just preliminary and again not conclusive. Same reaction on indexes. I wonder if Securities and Exchange Commission is having a closer look at this development. Because it is way too big coincidence for being it just a coincidence.
Well same old story as on 17 April. At that moment it looked like the shares are loosing their momentum. What is worse major macro-data were supposed to be released (especially China quaterly GDP) and also an information about record number of dead people in the USA due to coronavirus. So after-market we got the amazing Gilead trials report which in fact was not conclusive at all and did not present anything new. Nevertheless, it was published like something great which will save the human mankind and of course got a lot of attention and main headlines in major investor´s news like Bloomberg, CNBC, WSJ or here...And it did the job - pumped the indexes by 2 % in less thatn 30 minutes. Now Gilead is back. Coincidence? Not at all. Yesterday the markets were down and could have continued to be also today due to major macro (again GDP but this time US or pending home sales etc.) being released today. So what worked last time could do the job also today.
Last week, they said the same drug didn't work and market fell. Now they said the same drug works. Who knows...next week China finds out the drug doesn't work and markets collapse.
So the market trades like a biotech stock now?
it goes up if there is good news. it goes up if there is bad news.
I'm fortunate Reuters isn't my broker
Do you come here only for the comments? 🤓 I skip the propaganda, and only the comments. 🗽
The sentiment IS fairly clear-cut...and based on facts about GILD making a NINETEEN (19) person study -- which is not peer-reviewed or even AVAILABLE to the public -- and they claim Fauci was praising it... now Fauci claims GILD TOLD HIM its praise-worthy, each pointing fingers at the other, but not saying, "I am the one putting MY stamp-of-approval on this."
This isn't a vaccine though... This only helps people that are already at that hospital, it doesnt prevent it.
Making money on lie
you trade nasdaq
The drug shows 68% improvement if hospitals give it to u early. It is good but still not a cure.
...and this was on only a 19-person sample of patients!
According to CDC only 50% of flu vaccines are useful due to matching vaccine with flu strain due to virus mutation. Fighting yesterday's war IMO. Think the CV19 vaccine will be different? The CV vaccine is peddled by Faust Fauci as the cure for this plague. Think again IMO. The only thing is a drug that if some gets this crrap the have something to fight it like Gilead's or French cocktail.
financiers and traders are spending more time on government websites then the market. waiting for my handout.
biggest achievement in the world... anti virus drug in 3 months time
full margin tesla . amarzon
tomorrow is Gilead sciences earnings day and they came up with this news to prop up the stock....there has been no change from last time...and they have admitted that there was no control group either....besides this virus has many different strains operating....till we get a vaccine whic is long ways away...nothing is going to cure people over night suffering from this disease...
vaccines, vaccines, vaccines.....if they were all about health, then why not mandate healthy eating. Big pharma is set to profit nicely, especially with the help of their paid media outlets.
mandate eating? Whats next? Mandate my s hit too. If it goes that way, Soon enough we r all treated like robots.
I am not saying we should do that. I'm saying if vaccines were about health then why not mandate healthy eating. that's if they try to mandate a vaccine on us all, which I am against.
Ah—- rigged —- released same time as GDP while last week Gild put out a statement it was to early to tell— Fake news provides hope I guess and then the shills come out to pump
WHO release fake news from China.
 as opposed to fake news from Trump?   Like this latest gem:  "The only reason the U.S. has reported one million cases of CoronaVirus is that our Testing is sooo much better than any other country in the World. Other countries are way behind us in Testing, and therefore show far fewer cases!"
again? shld it be jump 2000p if we found treatment? 😂
68% is not small but is not a cure.
People will still get sick and hospitalized. Even if we have drugs that will prevent anyone to die, and lets hope that we will have life saving treatments sooner than later, nobody wants to get hospitalized! So its not going back to be as before until we have vaccines. And now the market is where it was late 2019? Already? That’s just crazy.
I don't want a vaccine and I hope it fails.  Thank you.
this doesn't make any sense, who is buying Al those stocks, no good news out there at all for several weeks!
Exactly!!! and they just keep circulating the same BS, day in day out. ON HOPES OF.
Forget about a vaccine - not going to happen. Think about being productive.
for such a good news only 500+?
governemnt buying. we sit in lockdown with no shot to get a piece. sad
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.